Skip to content

Tricia Lyn Westhoff-Pankratz, M.D.

NPI 1902834393ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Santa Barbara, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Santa Barbara, California, trained at University of California, Geffen School of Medicine (class of 1997). Their prescriptions cost Medicare Part D more than their services did: $2,380,091 for 5,746 claims, against $340,708 paid for services in 2024. Novo Nordisk Inc was the largest of 26 companies reporting payments in 2025, $2,701 in all, mostly food and beverage.

Overview

NPI1902834393
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJun 28, 2006
Last updated in NPPESOct 10, 2025
Certified by providerOct 10, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients853
Services billed35,065 across 30 procedure codes
Paid by Medicare$340,708

Part D prescriptions in 2024

Prescriptions (claims)5,746 · 14,297 30-day fills
Patients809
Total drug cost$2,380,091
Generic share60% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of California, Geffen School of Medicine
Graduation year1997
Medicare specialtyEndocrinology
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$2,701 · 108 payments from 26 companies
  • 2024$4,992 · 240 payments from 32 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$398.3022
Sequel Med Tech, LLC$280.429
Xeris Pharmaceuticals, Inc.$240.7812
Abbott Laboratories$217.345
Amgen Inc.$183.258

What the 2025 payments were for

  • Food and Beverage$2,691 · 107 payments
  • Education$10.02 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Santa Barbara

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →